| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 11/11/2004 | WO2004096178A1 Nano and microparticle drug delivery systems comprising polyesters containing aliphatic dicarboxylate residues and residues of aliphatic polyols |
| 11/11/2004 | WO2004096177A1 Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts |
| 11/11/2004 | WO2004096176A2 Solid drug formulation and device for storage and controlled delivery thereof |
| 11/11/2004 | WO2004096175A2 Taste masked microcapsules and processes for their preparation |
| 11/11/2004 | WO2004096174A1 Fast dissolving orally consumable films containing pharmaceutically active agents |
| 11/11/2004 | WO2004096173A2 Method for the dispersion of water-soluble or hydrophilic substances in a supercritically pressurized fluid |
| 11/11/2004 | WO2004096172A2 Vector for oral administration |
| 11/11/2004 | WO2004096155A2 Tablets and methods for modified release of hydrophilic and other active agents |
| 11/11/2004 | WO2004096152A2 In situ gelling self-reactive materials for embolization |
| 11/11/2004 | WO2004096151A2 Methods and devices for the sustained release of multiple drugs |
| 11/11/2004 | WO2004096150A2 Oral pharmaceutical delivery system with improved sustained release |
| 11/11/2004 | WO2004096146A2 Method and composition for preventing, reducing and reversing ocular ischemic neuronal damage |
| 11/11/2004 | WO2004096140A2 Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds |
| 11/11/2004 | WO2004096127A2 Formation of strong superporous hydrogels |
| 11/11/2004 | WO2004096125A2 Pharmaceutical compositions releasing their active agents from a buccal or sublingual location to overcome an absorption window problem |
| 11/11/2004 | WO2004096118A2 Composition for improving cognition and memory |
| 11/11/2004 | WO2004096104A1 Prosthetic foot with tunable performance and improved vertical load/shock absorption |
| 11/11/2004 | WO2004095955A1 A flameless electronic atomizing cigarette |
| 11/11/2004 | WO2004095946A2 Medical food tablets containing free amino acids |
| 11/11/2004 | WO2004095942A2 Caffeinated tablet |
| 11/11/2004 | WO2004095921A2 Sporicidal composition |
| 11/11/2004 | WO2004082626A3 Aromatase inhibitor diagnosis and therapy |
| 11/11/2004 | WO2004075825A3 Dosage forms of amlodipine and processes for their preparation |
| 11/11/2004 | WO2004073743A3 Use of a volatile liquid at atmospheric pressure and ambient temperature for the production of pharmaceutical or biological compositions |
| 11/11/2004 | WO2004073684A3 Lipophilic drug delivery vehicle and methods of use thereof |
| 11/11/2004 | WO2004073614A3 Combination therapy for the treatment of immunoinflammatory disorders |
| 11/11/2004 | WO2004073597A3 Bioadhesive liquid composition which is substancially free of water |
| 11/11/2004 | WO2004071452A3 Random and non-random alkylene oxide polymer alloy compositions |
| 11/11/2004 | WO2004069224A3 Stable sterile filterable liposomal encapsulated taxane and other antineoplastic drugs |
| 11/11/2004 | WO2004066911A3 Suspension vehicle for coated drug particles |
| 11/11/2004 | WO2004064876A3 Anti-microbial nonwoven wipe |
| 11/11/2004 | WO2004064726A3 Bioavailable fenofibrate compositions, methods for treating hyperlipidemia and hypercholesterolemia and processes for the preparation of such compositions |
| 11/11/2004 | WO2004063152A3 Lansoprazole formulations and related processes and methods |
| 11/11/2004 | WO2004058168B1 METHODS OF TREATING NON-PAINFUL BLADDER DISORDERS USING α2δ SUBUNIT CALCIUM CHANNEL MODULATORS |
| 11/11/2004 | WO2004056340A3 Stabilised solid drug dispersions in an organic carrier and a process for preparing the same |
| 11/11/2004 | WO2004035021A3 Buccal polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| 11/11/2004 | WO2004032903A3 Method for producing solid galenic formulations using a crosslinked non-thermoplastic carrier |
| 11/11/2004 | WO2004014849A3 Isosorbide mononitrate compositions and methods of their use |
| 11/11/2004 | WO2003087411A8 Method to inhibit cell growth using oligonucleotides |
| 11/11/2004 | US20040225338 Ambulatory medical apparatus and method using a robust communication protocol |
| 11/11/2004 | US20040225281 Infusion device and driving mechanism for same |
| 11/11/2004 | US20040225140 Pharmaceutical composition for the treatment of psoriasis and other skin diseases |
| 11/11/2004 | US20040225110 Method for enhancing integrity of epithelium using retinoic acid |
| 11/11/2004 | US20040225077 tissue adhesion; hemostatic agents; biocompatibility gel ; in vivo administering of a drug |
| 11/11/2004 | US20040225022 Propofol formulation containing reduced oil and surfactants |
| 11/11/2004 | US20040225020 optically pure (-)-bupropion is effective in aiding or achieving smoking cessation while avoiding adverse effects associated with the administration of racemic bupropion. |
| 11/11/2004 | US20040225011 E.g., ajulemic acid; used for decreasing cell proliferation |
| 11/11/2004 | US20040224949 Modified release formulations of at least one form of tramadol |
| 11/11/2004 | US20040224905 Applying to an area in need thereof, an effective amount of a one or more rhamnolipids for therapy of gingivitis |
| 11/11/2004 | US20040224903 Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device |
| 11/11/2004 | US20040224890 Nasal calcitonin formulations containing chlorobutanol |
| 11/11/2004 | US20040224876 Combination therapy for the treatment of immunoinflammatory disorders |
| 11/11/2004 | US20040224073 Soluble roasted chicory having high inulin content |
| 11/11/2004 | US20040224060 A homogeneous extruded product comprising decorticated Milo seeds and fungicides, selected from a solid chlorine mixture, sodium nitrate, and garlic extract; use in building industry, construction materials, basements, prevent mold growth |
| 11/11/2004 | US20040224032 Composition comprising micro-encapsulated iron |
| 11/11/2004 | US20040224030 Microsphere delivery systems |
| 11/11/2004 | US20040224029 Particle possessing a membrane |
| 11/11/2004 | US20040224027 useful for tissue regeneration, particularly when used with orthopedic implants and drug delivery |
| 11/11/2004 | US20040224026 Collagen/polysaccharide bilayer matrix |
| 11/11/2004 | US20040224025 Fish gelatin compositions containing a hydrocolloid setting system |
| 11/11/2004 | US20040224023 Compositions and methods for treating or preventing diseases of body passageways |
| 11/11/2004 | US20040224022 Collagen/polysaccharide bilayer matrix |
| 11/11/2004 | US20040224021 combining at least one ethylenically-unsaturated monomer, a cross-linking agent and an ionic polysaccharide with one or more cations to form a mixture, subjecting mixture to polymerization to form hydrogel, reacting hydrogel with one or more cations under equilibrating conditions; strength, resilience |
| 11/11/2004 | US20040224020 selectively enhancing analgesic potency of an opioid agonist or attenuating an adverse side effect of the opioid agonist; e.g. controlled release core comprises oxycodone, and the immediate release gelatin capsule comprises oxycodone and an opioid antagonist such as naltrexone |
| 11/11/2004 | US20040224019 tissue targeted therapy; solid nanospheres encapsulated in a microsphere formed of a pH sensitive or salt sensitive matrix material, with nucleic acid incorporated into the nanosphere; dosage forms |
| 11/11/2004 | US20040224018 labile agent such as human growth hormone complexed with zinc for example; wet milling suspension of labile agent dispersed in biocompatible polymer and solvent to submicron particles of labile agent; drying to form solid polymer/labile agent matrix; sustained release formulation |
| 11/11/2004 | US20040224017 maltodextrin to a drug formulaton containing water insoluble cellulose (especially starch, cellulose ether, xanthan gum or microcrystalline cellulose) to retard the rate of release of the drug to the desired drug release profile when placed in an aqueous system |
| 11/11/2004 | US20040224016 particles of biologically active, non-aggregated erythropoietin in contact with a salting-out salt dispersed within a biodegradable polymeric matrix; smaller amounts of EPO are used compared to bolus injection regimen because serum EPO levels are maintained closer to therapeutical thresholds. |
| 11/11/2004 | US20040224015 Binder composition and method for processing poorly compressible drugs into tablets of predetermined hardness and friability |
| 11/11/2004 | US20040224014 particularly norfloxacin, containing an inorganic or organic acid stabilizer; for preparing a tablet by wet granulation |
| 11/11/2004 | US20040224013 Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue |
| 11/11/2004 | US20040224012 Topical application and methods for administration of active agents using liposome macro-beads |
| 11/11/2004 | US20040224011 unilamellar liposomes with a diameter of 100-150 nanometers, not bound to a drug: and a carrier; slows progression of atherosclerotic lesions as well as causes regression and shrinkage of established plaques |
| 11/11/2004 | US20040224010 Ophthalmic liposome compositions and uses thereof |
| 11/11/2004 | US20040224008 hydrophilic polymer adapted to dissolve when exposed to moisture and a non-hydrophilic region encapsulated within the region adapted to at least partially inhibit migration of water, active agents or other molecules the backing and adapted to disperse when no longer encapsulated |
| 11/11/2004 | US20040224007 dissolvable transmucosal delivery devices that can be used to isolate a drug against a mucosal layer but which will dissolve or otherwise disintegrate over time when exposed to moisture (e.g., saliva); backing layer adapted to protect adhesive layer from over-moistening |
| 11/11/2004 | US20040224002 Artificial synapse chip |
| 11/11/2004 | US20040224000 Implants for non-radioactive brachytherapy of hormonal-insensitive cancers |
| 11/11/2004 | US20040223999 Mold inhibitor integrated within a matrix and method of making same |
| 11/11/2004 | US20040223997 Antifungal parenteral products |
| 11/11/2004 | US20040223985 electronically controllable device for delivery of fluid to a targeted location on epidermal tissue |
| 11/11/2004 | US20040223984 Topical testosterone formulations and associated methods |
| 11/11/2004 | US20040223983 Pharmaceutical preparations, use of these preparations and process for increasing the biovailability of pharmaceutical substances to be administered perorally |
| 11/11/2004 | US20040223961 Enzyme treatment |
| 11/11/2004 | US20040223958 Glutathione reductase for therapy and prophylaxis of AIDS |
| 11/11/2004 | US20040223946 applying an adhesive composition comprising a polymerizable alpha -cyanoacrylate monomer optionally with an additional active agent such as an antipruitic agent to the insect bite; and allowing the monomer to polymerize to form a film over said area of skin with the bite. |
| 11/11/2004 | US20040223922 Clear micellized formulations of beta-carotene and method of treating leukoplakia |
| 11/11/2004 | US20040223920 Treating disease of the airway passages and lungs such as asthma and allergic rhinitis by administering intranasally or oral inhalation; low bioavailability and low systemic side-effects; aerosols |
| 11/11/2004 | US20040223919 for dispensing a cosolvent and surfactant-free formulation including a 1,1,1,2-tetrafluoroethane and 1,1,1,2,3,3,3-heptafluoro-n-propane propellant |
| 11/11/2004 | US20040223918 includes ethanol as a high volatility carrier and an optional additive such as a surfactant and/or low volatility liquid; propellant-free |
| 11/11/2004 | US20040223917 Liquid aerosol formulations containing insulin and aerosol generating devices and methods for generating aerosolized insulin |
| 11/11/2004 | US20040223916 for a metered dose inhaler having part or all of its internal surfaces coated with one or more fluorocarbon polymers, optionally in combination with one or more non-fluorocarbon polymers and having a wall with a thickness of 0.55 mm to 1.00 mm |
| 11/11/2004 | US20040223914 comprises void containing vapor of volatile liquid perfluorocarbon, combined with aqueous solution to form contrast agent, for oral/rectal administration or injection; for gastrointestinal imaging/tomography |
| 11/11/2004 | US20040223911 Stabilized therapeutic and imaging agents |
| 11/11/2004 | US20040221868 Preparations for sustained release of nutraceuticals and methods of controllably releasing nutraceuticals |
| 11/11/2004 | DE202004009563U1 Sustained release pharmaceutical composition containing tamsulosin comprises specific dissolution profile ensuring high activity without side-effects, useful for treating urinary disorders such as benign prostate hyperplasia |
| 11/11/2004 | DE10317692A1 Medizinische Wirkstoffpflaster mit veringerter optischer Auffälligkeit auf der Haut Medical active substance patch with veringerter optical conspicuousness on the skin |
| 11/11/2004 | DE10317108A1 Transdermal applizierbares Beruhigungs- und Sedierungsmittel Transdermally administrable sedatives and Sedierungsmittel |
| 11/11/2004 | DE10317023A1 Oral dosage form useful in the treatment and prevention of gastrointestinal disorders e.g. inflammatory disorders and lesions such as gastric ulcer comprises proton pump inhibitor and basic excipients |
| 11/11/2004 | DE10316087A1 Stabilizing polymorphic forms of fluvastatin sodium in solid medicaments, for use as HMG-CoA reductase inhibiting cardiovascular drugs, by adjusting water content and water activity values |